Both in Pharmaceuticals
Artelo Biosciences vs Jaguar Health
Over the past year ARTL returned −97.6% and JAGX returned −99.3%; their daily moves had a correlation of -0.08.
ARTL −97.6% JAGX −99.3%Growth of $1, one year, split-adjusted
| Metric | ARTL | JAGX |
|---|---|---|
| Price | $2.70 | $3.53 |
| Market cap | $1.5M | $6.9M |
| Today | −1.46% | +207.19% |
| 1 month | −32.0% | +156.4% |
| 6 months | −93.2% | −96.6% |
| Year to date | −91.8% | −98.4% |
| 1 year | −97.6% | −99.3% |
| Revenue growth (YoY) | — | −58.9% |
| Gross margin | — | 15.8% |
| Net margin | — | −1036.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.2× |
| Net cash | $4.2M | -$11.8M |
| Dividend yield | — | — |
| Volatility (60d) | 651.1% | 1,064.0% |
| Short % of float | 1.0% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).